girasol

Sunflower (Helianthus annuus L.): A Comprehensive Reference

1. Identity and Botanical Classification

The common sunflower (Helianthus annuus L.) is a species of the Asteraceae family grown commercially worldwide, offering a variety of nutritional and medicinal benefits. The genus Helianthus, belonging to the Asteraceae family, encompasses 67 species, of which Helianthus annuus L. is the most widely propagated, known as the common sunflower. It is an annual dicotyledonous plant widely distributed across North America, Eastern Europe, and Northern China for production of oils, seeds, and snacks. A native of North America, this species is easy to grow due to the length and depth of its roots, which favor its resistance to changes in temperature and humidity; it is currently cultivated on all five continents of the globe.

There are two main types of sunflower: the oil-type and the confections-type (non-oil, mainly for human consumption). Almost 70–80% of cultivated sunflowers belong to the oil type, which is further sub-categorized into three groups: the traditional, mid-oleic (NuSun), and high-oleic (over 80% oleic acid), with seed oil content usually ranging between 39–49%.

1.1 Common Forms and Preparations

The sunflower plant yields multiple distinct commercial and supplemental preparations:

• Whole seeds (raw, roasted, or dried): Sunflower seeds are eaten raw, roasted, cooked, dried, and ground, and used as a source of oil.
• Sunflower seed oil: Sunflower oil is one of the most common edible oils, obtained by the mechanical pressing of sunflower seeds. The oil is mainly used for cooking and shortening, and for preparing salad dressing and margarine.
• High-oleic sunflower oil (HOSO): Plant breeding produced varieties with improved fatty acid profiles, such as high-oleic sunflower oil, and at the same time resistant to insects.
• Sunflower seed flour/meal: The crop's multiple uses included milling for flour or meal production to make bread and cakes.
• Sunflower seed extract (standardized): Concentrated extracts standardized for chlorogenic acid content are used as dietary supplements, typically in capsule or tablet form.
• Sunflower lecithin: Sunflower lecithin powder is a phospholipid-rich extract derived from the seeds of Helianthus annuus, serving as a natural emulsifier and dietary supplement, primarily composed of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol.
• Sunflower sprouts: The sunflower seed and sprout contain valuable antioxidant, antimicrobial, anti-inflammatory, antihypertensive, wound-healing, and cardiovascular benefits found in its phenolic compounds, flavonoids, polyunsaturated fatty acids, and vitamins.
• Essential oil (from receptacle): The yield of essential oil from the sunflower receptacle is about 0.42% (v/w) by hydrodistillation; 68 volatile components have been identified by GC-MS, with the main constituents being α-pinene (26.00%), verbenone (7.40%), terpinolene (1.69%), and α-terpineol (1.27%).

2. Traditional and Historical Use

2.1 Indigenous North American Use

Sunflower (Helianthus annuus, Asteraceae), native to North America, was used by indigenous people since as early as 3000 BCE. The seeds were eaten as a snack, ground into a meal, baked into bread, and pressed for oil. Medicinally, sunflower was used in the treatment of snakebites. A purple dye from the plant was used for body paint and textiles. The oil was applied to skin and hair as a moisturizer. The stalks created a building material, and flowers and seeds were included as part of ceremonies.

The sunflower is a native domesticated crop. During the last 3,000 years, Indians increased the seed size approximately 1,000 percent, gradually changing the genetic composition of the plant by repeatedly selecting the largest seeds. The Mescalero and Chiricahua Apache made extensive use of wild sunflowers. The Hidatsa used wild versus cultivated sunflowers in the production of cooking oil because the seeds of their smaller flower heads produced superior oil. The roasted seeds have also been used as a coffee substitute.

Some archaeologists suggest that sunflower may have been domesticated before corn. The sunflower's oils and pigments were used as a sunscreen or the basis for a purple dye for skin, hair, or textile decoration, while the plant's sturdy, fibrous stem was exploited in construction.

2.2 Ethnomedicinal Use Across Cultures

Sunflower is used in ethnomedicine for treating a number of disease conditions including heart disease, bronchial, laryngeal and pulmonary infections, coughs and colds, and in whooping cough. H. annuus has been pharmacologically studied for various activities including anti-inflammatory, antioxidant, antitumor, antiasthmatic, antipyretic, astringent, antihypoglycemic, antifungal, cathartic, diuretic, stimulant, vermifuge, vulnerary, and antimicrobial activities.

2.3 European Introduction and Russian Commercialization

In the 16th century, sunflowers were taken to Europe and cultivated there, mainly as an ornamental. It was brought by Spanish mariners in 1510. They started cultivating sunflower, leading to increases in grain size and oil content. However, the plant could not gain popularity as the Spanish preferred olives, and the yellow flower was used as decorative for nearly two centuries.

Sunflower became a vital oilseed crop globally after the Russians bred the Mammoth Russian variety, increasing the size of the heads and the seed oil content from 28% to almost 50% by 1860. These new varieties were reintroduced back to the U.S. in 1893. The Orthodox Church acknowledged sunflower oil as a lenten-diet product and promoted it for society. Research in the 1970s showed that sunflower oil was a healthier alternative to the traditionally-used saturated fats. Europeans, in particular, switched to sunflower oil products and demand quickly outstripped supply, causing the crop to boom.

3. Key Constituents and Active Compounds

3.1 Macronutrient Composition of Seeds

Fat is the main component found in sunflower seeds, with a content of 44–52%, followed by protein at 28–32%. The important fatty acids found in sunflower seeds are 62–69% linoleic acid and 20–25% oleic acid. According to the USDA, a 100-gram sunflower seed contains 20.78 grams of protein, 51.46 grams of lipids, 3.02 grams of ash, and 20 grams of carbohydrates.

3.2 Fatty Acid Profile

Regular sunflower oil contains 69% linoleic acid, 20% oleic acid, and 11% saturated fatty acids. There are two main types: normal sunflower, which has a linoleic acid content between 50% and 70%, and high-oleic sunflower, which has 2–10% linoleic acid and 75–90% oleic acid. In its native form (crude oil), conventional sunflower oil may contain high amounts of linoleic acid (C18:2, 48–74%) and high amounts of tocopherols (403–935 mg/kg).

3.3 Tocopherols (Vitamin E)

Sunflower seeds are also a rich source of tocopherols (vitamin E), chlorine, betaine, lignans, arginine, and phenolic acid. Linoleic acid is the most abundant fatty acid in sunflower oil samples; the mean contents of total tocopherols, phenols, carotenoids, and chlorophyll are 518.24, 9.42, 7.54, and 0.99 mg/kg, respectively. Sunflower seeds are an excellent source of vitamin E, providing 49% of the daily value per one-ounce serving.

3.4 Phenolic Compounds and Chlorogenic Acids

The compounds identified across all parts of the sunflower include phenolic acids, flavonoids, and terpenes as the main classes. These metabolites are responsible for the pharmacological effects of the species, especially 5-O-caffeoylquinic acid (chlorogenic acid) and its derivatives.

Phenolic compounds account for 1–4% of the total mass of sunflower residues from oil extraction, chlorogenic acids (CGAs) being the major components. Chlorogenic acids are a class of polyphenol compounds formed by esterification of cinnamic acid with (−)-quinic acid, abundantly found in the human diet.

The phenolic compound contents in defatted sunflower seed flour, determined as chlorogenic acid (CGA) equivalent, can present 11.57 and 15.44 g CGA eq/100 g for sodium bisulfite and ethanolic extracts, respectively.

3.5 Flavonoids

The seeds are a source of antioxidant flavonoids including quercetin, luteolin, apigenin, and kaempferol. Helianthus annuus contains various bioactive compounds including phenols, terpene compounds, carbohydrates, flavonoids, tannins, alkaloids, saponins, steroids, fixed oil, and active proteins, all of which contribute to its medicinal properties.

3.6 Phytosterols

Sunflower seeds contain approximately 270–289 mg of phytosterols per 100 grams, particularly beta-sitosterol, delta5-avenasterol, and campesterol.

3.7 Vitamins and Minerals

The seeds are a source of vitamins E, B, folate, and niacin, and minerals including principally calcium, copper, iron, magnesium, manganese, selenium, phosphorus, potassium, sodium, and zinc. The amino acid profile includes glutamic acid, aspartic acid, arginine, phenylalanine, tyrosine, leucine, methionine, and cysteine.

3.8 Lecithin Phospholipids

Sunflower lecithin is a phospholipid-rich extract derived from the seeds, primarily composed of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol. Data on phospholipid composition for sunflower lecithin (liquid, de-oiled) has been characterized by 31P nuclear magnetic resonance spectroscopy.

4. Mechanisms of Action

4.1 Antioxidant Activity

Chlorogenic acid (CGA) is a mild polar phenolic compound composed of a quinic acid and a caffeic acid part linked by an ester bond. It has antioxidant properties through free radical scavenging and metal chelation activities. The ORAC, DPPH, and ABTS methods have been used to evaluate antioxidant activity in sunflower extracts; both sodium bisulfite and ethanolic extracts present antioxidant properties, with the ethanolic extract demonstrating higher values.

4.2 Anti-inflammatory Mechanisms

Chlorogenic acid executes its anti-inflammatory function by moderating the synthesis and secretion of inflammatory mediators, namely TNF-α, IL-1β, IL-6, IL-8, NO, and PGE2. Concurrently, it modulates key signaling pathways and associated factors including NF-κB, MAPK, and Nrf2, bestowing cellular and tissue protection.

In vitro assays have shown that a chlorogenic-acid-rich sunflower fraction, at concentrations corresponding to 50 or 100 µM of CGA, does not present cytotoxicity on human THP-1 macrophage cells, and when added prior to an inflammatory stimulus (LPS), can reduce TNF-α production by 22%.

4.3 Glucose Metabolism and Hypoglycemic Mechanisms

Chlorogenic acid (CGA), the principal bioactive constituent of sunflower polyphenols, inhibits glucose-6-phosphatase translocase, an enzyme responsible for converting glucose-6-phosphate into glucose, thereby reducing hepatic glucose production and alleviating hyperglycemia. Certain constituents in sunflower seed extracts also function as alpha-glucosidase inhibitors, suppressing intestinal brush-border enzymes and consequently diminishing carbohydrate digestion and absorption, assisting in controlling postprandial hyperglycemia.

4.4 Skin Barrier Mechanisms

Linoleic acid — the primary essential fatty acid component in sunflower seed oil — binds specifically to receptors in keratinocytes that mediate skin development, thus accelerating this process, and has a direct role in epidermal barrier permeability repair, and repair of skin barrier function in states of nutritional deficiency. Sunflower seed oil is high in linoleic acid, which has previously demonstrated benefit to the skin barrier by increasing peroxisome proliferator-activated receptor alpha (PPAR-α) and reducing inflammation.

5. Scientific Evidence by Area of Use

5.1 Cardiovascular Health and Lipid Profile

Summary: The evidence for cardiovascular benefits of sunflower oil and seeds is moderate for lipid-lowering effects, supported by multiple controlled clinical trials, though results are variable depending on the oil type used (conventional, high-oleic) and the comparison arm.

There is supportive evidence that 20 g of an oil containing high levels of oleic acid, when replacing fats and oils higher in saturated fat, can reduce the risk of coronary heart disease. The replacement of saturated fatty acids with polyunsaturated fatty acids was also shown to reduce coronary heart disease events, with a 13% lower risk for each 5% greater PUFA intake in place of saturated fat.

In one study, sixty men with high LDL-cholesterol levels consumed bread made using 7.5% sunflower-seed flour daily for four months, which increased intake of linoleic acid. At the end of the four-month period, total cholesterol had fallen by approximately 9 mg/dL, with LDL-C falling by 3.41 mg/dL (2.1%). A randomized controlled trial also found that a daily dose of 25 mL of sunflower oil lowered LDL-C by 10.8% over a seven-week intervention; 25 mL of sunflower oil is approximately equivalent to the fat content of 50 grams of sunflower seeds.

A study investigated the influence of dietary therapy containing sunflower oil with phospholipids on the lipid profile of patients with hypertension and obesity. After three weeks, the unrefined sunflower oil supplemented with phospholipids (30 g oil containing 10.8 g phospholipids) had more influence on lowering blood pressure, particularly diastolic BP, and reduced serum total cholesterol, LDL, apolipoprotein A1, apoB, and fibrinogen more than the refined sunflower oil diet.

Two randomized, blinded, cross-over controlled clinical trials were carried out in 65 normocholesterolemic and 67 moderately hypercholesterolemic subjects, each lasting fourteen weeks with two four-week intervention phases using olive pomace oil versus high-oleic sunflower oil or conventional sunflower oil, each preceded by a three-week run-in or washout period. In a separate randomized controlled trial comparing sunflower oil and rapeseed oil in adults with overweight and obesity over 12 weeks, no differences in coronary artery disease or chronic kidney disease biomarker scores were observed. The replacement of habitual fat with either rapeseed oil or sunflower oil for 12 weeks did not lead to an improvement or worsening in cardiovascular health markers. Notably, median 8-isoprostane — a marker of oxidative stress — was approximately 50% higher in the sunflower oil group after 12 weeks compared to rapeseed oil and control groups.

Evidence strength: Moderate. Multiple short-term randomized controlled trials demonstrate lipid-lowering effects of sunflower oil, particularly reduction in LDL-C, when substituted for saturated fats. However, some trials show no significant cardiovascular benefit, and one trial noted higher oxidative stress markers with conventional sunflower oil at 12 weeks. The high linoleic acid content of conventional sunflower oil is recognized as a potential concern for oxidative stress under certain conditions.

5.2 Body Weight, Obesity, and Metabolic Function

Summary: Preliminary but promising clinical evidence supports the use of chlorogenic acid-standardized sunflower seed extract for reducing body fat and improving metabolic parameters in overweight and obese adults. Evidence is limited by small sample sizes and short durations.

A pilot study evaluated the effects of a sunflower (Helianthus annuus) seed extract, standardized for 40% chlorogenic acids, on weight and body composition in obese adults. Fifty subjects were randomly assigned to sunflower extract or isocaloric placebo groups, receiving 500 mg/day of treatment for 12 weeks. At the end of the intervention, a significant decrease in body weight, BMI, and waist circumference was observed, especially for obese female subjects above 30 years, associated with fat mass loss. A decrease in blood cholesterol was also observed.

In a larger double-blind, randomized, placebo-controlled study, 100 adults with BMIs of 25 to 31.9 kg/m² were assigned to groups receiving sunflower chlorogenic acid extract (SUN-CA, n=50) or placebo (n=50), each receiving 1 tablet/day containing 500 mg over a 12-week period. The primary endpoint was change in body fat mass and percentage. The SUN-CA group showed decreases in body fat mass greater than the placebo group (−0.9 ± 1.8 kg vs. −0.1 ± 1.4 kg; P=0.043). Body weight, BMI, and hip circumference also improved, with no intergroup differences in adverse events.

Chlorogenic acids have been reported to have hypolipidemic, hypoglycemic, and antidiabetic effects by regulating glucose and lipid metabolisms. In vitro and in vivo studies report that CGAs could improve glucose tolerance, stimulate insulin secretion, improve insulin resistance, and reduce postprandial blood glucose levels.

Evidence strength: Preliminary. The two randomized controlled trials cited are encouraging but of short duration (12 weeks), with relatively small sample sizes. Both used 500 mg/day of standardized sunflower extract. Larger, longer-duration trials are needed before firm conclusions can be drawn.

5.3 Blood Glucose and Diabetes Management

Summary: Evidence is predominantly preclinical (in vitro and animal), with emerging mechanistic rationale. Dedicated human clinical trials specifically on sunflower constituents for glycemic control remain limited.

Sunflower seeds contain chlorogenic acid, linoleic acid, tocopherols, flavonoids, and phytosterols, which have synergistic hypoglycemic, antioxidant, and anti-inflammatory effects, and are studied as a promising natural adjunct in diabetes management.

In vitro and in silico assays have suggested the inhibitory potential of chlorogenic acid and sunflower meal extract on α-glucosidase, supporting a possible antidiabetic effect. Chlorogenic acid modulates key signaling pathways including NF-κB, MAPK, and Nrf2, bestowing cellular protection against conditions including diabetes mellitus.

Evidence strength: Weak for human clinical outcomes. The mechanistic and preclinical evidence is substantial, and the human weight-management trials noted secondary reductions in blood cholesterol, but dedicated, adequately powered human trials on glycemic endpoints using sunflower preparations are lacking.

5.4 Dermatological Applications — Skin Barrier, Atopic Dermatitis, and Wound Healing

Summary: This is one of the best-supported areas of sunflower oil research, with multiple randomized trials demonstrating skin barrier enhancement, emollient efficacy in atopic dermatitis, and protective effects in neonatal populations.

The evidence points to at least a modest effect for sunflower seed oil in atopic dermatitis. A study of 86 children with moderate atopic dermatitis, randomized to corticosteroids with or without a sunflower-oil-containing cream, found a significant impact on lichenification and excoriation, decreased corticosteroid use, and improved quality of life compared to the control group.

Topical application of emollients containing coconut oil- and sunflower seed oil-derived fatty esters may improve itch, reduce topical steroid use, and reduce the relative abundance of S. aureus in mild-to-moderate atopic dermatitis, as concluded in a prospective randomized double-blind vehicle-controlled study.

Despite the availability of effective medications for the management of atopic dermatitis and xerosis, patients frequently use nonconventional therapies such as topical oils, choosing them because of the perceived lower risk and fear of potential adverse effects of topical steroids. Review evidence suggests that olive oil may exacerbate xerosis and atopic dermatitis, while further studies are needed to make definitive recommendations regarding coconut and sunflower seed oil.

Many details are yet to be resolved, including the linoleic versus oleic acid content, the frequency of application, and the underlying skin issues; however, sunflower seed oil has been used for quite some time and will likely remain an important ally in dermatological practice.

5.5 Neonatal and Preterm Infant Applications

Summary: This area has the strongest clinical evidence base among all topical sunflower seed oil applications, supported by multiple randomized controlled trials conducted in low- and middle-income country settings.

Experimental trials of topical emollient therapy — primarily with sunflower seed oil (SSO) — in hospitalized very preterm infants under 33 weeks gestational age have demonstrated a 50% reduction in bloodstream infections and a 27% reduction in neonatal mortality rate. Hospitalized preterm infants with compromised skin barrier function treated topically with SSO have shown reductions in sepsis and neonatal mortality rate.

A population-based, cluster randomized, controlled trial was conducted in 276 clusters in rural Uttar Pradesh, India. All newborn infants identified through population-based surveillance within 7 days of delivery were enrolled. Exclusive, three-times-daily, gentle applications of 10 mL of SSO to newborn infants by families throughout the neonatal period were recommended in intervention clusters.

Beyond local metabolic effects, fatty acids can be absorbed into the bloodstream following topical applications, as demonstrated in preterm and sick newborn infants as well as in adults with essential fatty acid deficiency who were unable to adequately ingest and absorb EFAs via the gut.

Evidence strength: Moderate to strong for sepsis reduction in preterm/hospitalized neonates in low-resource settings, supported by randomized controlled trials published in peer-reviewed journals including The Lancet and PLOS Medicine. The evidence in healthy term infants or those in high-income settings is less conclusive.

5.6 Antimicrobial Activity

Summary: Evidence is primarily in vitro. No human clinical trials have been conducted specifically for antimicrobial indications of sunflower preparations.

The minimum inhibitory concentration (MIC) of sunflower receptacle essential oil against P. aeruginosa and S. aureus was 0.2 mg/mL. The MIC against S. cerevisiae was 3.2 mg/mL, and against E. coli and Candida albicans was 6.4 mg/mL, indicating high antibacterial and antifungal activities in vitro.

The antimicrobial action of sunflower phenolic extracts has been analyzed as minimal inhibitory concentration and minimal bactericidal concentration against four bacteria: Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Bacillus subtilis in vitro.

Evidence strength: Preliminary; in vitro only. Translation to clinical settings has not been established.

5.7 Prebiotic and Gut Microbiome Effects

Summary: Emerging in vitro evidence suggests that sunflower meal phenolic extract may have prebiotic properties, but human data are absent.

Sunflower meal extract is phenolic-rich and dominated by chlorogenic acid. The extract has been shown to promote growth of beneficial gut bacteria in vitro, suggesting prebiotic potential. Cell-based assays indicated attenuation of oxidative and nitrosative stress in LPS-stimulated BV2 murine microglial cells. Overall, the sunflower meal extract demonstrated promising bioactive properties under in vitro conditions, suggesting potential as a multifunctional and sustainable phenolic-rich ingredient for functional food applications.

Evidence strength: Very preliminary; in vitro only.

6. Nutritional Profile and Micronutrient Contributions

There are several vitamins in sunflower seeds, including vitamins B1 and B5, vitamin E, and folate. They also contain important minerals like copper, magnesium, selenium, and phosphorus.

A 28.35-gram (one-ounce) serving of sunflower seeds provides 9.32 grams of polyunsaturated fat, specifically linoleic acid.

Sunflower seeds provide an abundance of essential minerals, offering high copper, selenium, and phosphorus content.

Sunflower oil is considered a health-benefitting oil due to its low content of saturated fats, high levels of polyunsaturated fatty acids and monounsaturated fatty acids, and vitamin E. It has good oxidative stability, and high-oleic sunflower oil is suitable for industrial frying.

7. Body Systems and Health Areas of Association

• Cardiovascular system: Lipid profile modulation (LDL-C reduction), antithrombotic potential via phospholipids, antioxidant protection of vascular tissues via tocopherols.
• Metabolic / Endocrine system: Modulation of glucose metabolism, alpha-glucosidase inhibition, potential role in insulin sensitivity via chlorogenic acid.
• Integumentary system (skin): Barrier enhancement, emollient effects, atopic dermatitis management, wound healing, transepidermal water loss reduction.
• Immune system: Reported effects of sunflowers include antioxidant, anti-inflammatory, antimicrobial, antidyslipidemic, hypoglycemic, renal, and colon-protective activity.
• Gastrointestinal system: Prebiotic potential of sunflower meal phenolics; dietary fiber contribution from whole seeds.
• Musculoskeletal system: Magnesium and calcium content supporting bone and muscle physiology.

8. Dosage Forms and Dosages Reported in Studies

Dosages described below are drawn directly from clinical studies and are reported for reference only.

• Standardized sunflower seed extract (oral, weight/body composition): Fifty subjects were randomly assigned to sunflower extract or isocaloric placebo groups, receiving 500 mg/day of treatment for 12 weeks. In a separate double-blind, randomized, placebo-controlled study, 100 adults received 1 tablet/day containing 500 mg of sunflower chlorogenic acid extract (SUN-CA) over a 12-week period.
• Sunflower oil (oral, cardiovascular): A randomized controlled trial used a daily dose of 25 mL sunflower oil over a seven-week intervention and found a 10.8% reduction in LDL-C.
• Sunflower oil supplemented with phospholipids (oral, cardiometabolic): Unrefined sunflower oil supplemented with phospholipids at 30 g oil containing 10.8 g phospholipids daily over three weeks.
• Sunflower oil (topical, neonatal emollient): Exclusive, three-times-daily, gentle applications of 10 mL of sunflower seed oil to newborn infants throughout the neonatal period.
• Sunflower seed flour (oral, cardiovascular): Sixty men consumed bread made using 7.5% sunflower-seed flour daily for four months, leading to reductions in total cholesterol and LDL-C.
• High-oleic sunflower oil (oral, crossover trial): Participants consumed daily 45 g of high-oleic acid sunflower oil (HOSO) as control oil during 4 weeks in a randomized crossover trial.
• Conventional sunflower oil (oral, crossover trial): Participants consumed 45 g/day of sunflower oil for 4 weeks, each preceded by a 3-week run-in/wash-out phase.

9. Safety Considerations and Interactions

9.1 Allergic Reactions — Seeds

Symptoms of an allergic reaction to sunflower include bronchial asthma, allergic rhinitis, angioedema, acute urticaria, and oral allergy syndrome. The main allergens described in sunflower seed are the 2S albumin protein and a nonspecific lipid transfer protein (LTP), including Hel a 1, Hel a 2, Hel a 3, and Hel a 6. Sunflower seed allergen components have been known to contain proteins cross-reactive to mugwort pollen, such as Art v 1 and Art v 3.

People may experience allergic reactions after eating whole grain bread containing sunflower, because sunflower allergens are highly heat resistant and do not disintegrate even at temperatures as high as 200°C, even after 1 hour of baking.

Basophil activation testing in sunflower-allergic patients showed a positive basophil response to 2S albumin in 87.5% of cases, to oleosins in 60%, and to 11S albumin in 57.14%. 50% of patients were positive to all three proteins.

9.2 Sunflower Oil vs. Seed Allergy

The processing of edible oils usually alters the proteins present in sunflower oil, affecting solubility and resulting in a dramatic decrease in total protein content. Although sunflower oil is generally considered safe for patients with food allergies because it does not contain proteins, numerous exceptions have been confirmed. In a study of two patients allergic to sunflower seeds, traces of protein were found in cold-pressed sunflower oil, but during an open-label sunflower oil provocation, patients did not report any clinical symptoms.

9.3 Pollen Allergy (Respiratory)

Prevalence of sunflower pollen sensitization has been observed among 21% of the pollen-allergic population, associated with elevated levels of specific IgE and histamine. Immunoscreening of sunflower pollen proteome detected seven IgE-reactive proteins with varying molecular weights. Studies on workers of a sunflower processing industry demonstrated that regular exposure to sunflower pollen grains often resulted in occupational allergic syndromes including severe lung impairment, allergic rhinitis, and conjunctivitis.

9.4 Oxidative Stability and Heating

The fatty acid composition has a dominant effect on the oxidative stability of sunflower oils; the content of linoleic acid (C18:2), as the most dominant fatty acid, has a positive effect on oxidative deterioration indices, indicating that oxidative changes occur in linoleic acid after prolonged storage or heat exposure.

9.5 Lecithin and Drug Interactions

There are no well-documented significant drug interactions with sunflower lecithin; however, caution is advised for individuals taking anticoagulants due to the potential influence of phospholipids on platelet function. Contraindications include a known allergy to sunflower or any of its components.

9.6 Gastrointestinal Effects

Mild gastrointestinal discomfort, such as bloating or nausea, is possible but rare with sunflower lecithin. Allergic reactions to sunflower lecithin are also rare, especially compared to soy-derived lecithin, as sunflower lecithin is considered less allergenic.

9.7 Clinical Trial Safety Findings

In the 12-week double-blind, randomized, placebo-controlled trial of 500 mg/day sunflower chlorogenic acid extract in adults with obesity, there were no intergroup differences in the prevalence of adverse events.

References

• Petraru A et al. "A review of phytochemistry, metabolite changes, and medicinal uses of the common sunflower seed and sprouts (Helianthus annuus L.)." BMC Chemistry. 2017. PMC5622016.
• Pereira MJS et al. "Therapeutic Activities and Phytochemical Composition of Helianthus annuus L. Extracts." PMC12908930. 2025.
• Ameer K et al. "Nutritional, pharmaceutical, and health benefits of sunflower seeds (Helianthus annuus L.): A comprehensive review of food applications." ScienceDirect. 2025.
• USDA NRCS. "Annual Sunflower (Helianthus annuus L.) Plant Guide." USDA Natural Resources Conservation Service.
• American Botanical Council. "Sunflower — History, Cultivation, Immigration." HerbalGram. 2020.
• Nuseed. "History of the Sunflower." Nuseed Europe. 2019.
• Rabrenović B et al. "Investigation of oxidative characteristics, fatty acid composition and bioactive compounds content in cold pressed oils of sunflower grown in Serbia and Argentina." PMC10372673. 2023.
• ScienceDirect Topics. "Sunflower Oil — an overview." ScienceDirect.
• González-Rámila S et al. "Olive Pomace Oil versus High Oleic Sunflower Oil and Sunflower Oil: A Comparative Study in Healthy and Cardiovascular Risk Humans." Foods. 2022. PMC9331821.
• Moran N et al. "No evidence of differential impact of sunflower and rapeseed oil on biomarkers of coronary artery disease or chronic kidney disease in healthy adults with overweight and obesity." PMC9363295. 2022.
• Krachanova M et al. "Influence of dietary therapy containing sunflower oil fortified with phospholipids on the lipid metabolism in patients with hypertension and obesity." PubMed 17385451. 2007.
• Onakpoya IJ et al. "Helianthus annuus Seed Extract Affects Weight and Body Composition of Healthy Obese Adults during 12 Weeks of Consumption: A Randomized, Double-Blind, Placebo-Controlled Pilot Study." PMC6566515. 2019.
• Kim J et al. "Sunflower seed extract supplementation reduces body fat in adults with obesity: A double-blind, randomized, placebo-controlled trial." Nutrition. PubMed 38217909. 2024.
• Chen J et al. "Chlorogenic acid: a review on its mechanisms of anti-inflammation, disease treatment, and related delivery systems." PMC10534970. 2023.
• Vieira AF et al. "Evaluation of some in vitro bioactivities of sunflower phenolic compounds." PMC8482426. 2021.
• Fauconnier ML et al. "Multicriteria Optimization of Phenolic Compounds Capture from a Sunflower Protein Isolate Production Process by-Product by Adsorption Column." PMC8066219. 2021.
• Popa ME et al. "Nutritional Characteristics Assessment of Sunflower Seeds, Oil and Cake." PMC8619027. 2021.
• Tickell KD et al. "Topical emollient therapy with sunflower seed oil alters the skin microbiota of young children with severe acute malnutrition in Bangladesh." PMC8325932. 2021.
• Kumar A et al. "Effect of sunflower seed oil emollient therapy on newborn infant survival in Uttar Pradesh, India." PMC8478176. 2021.
• Ahmed T et al. "Effect of topical applications of sunflower seed oil on systemic fatty acid levels in under-two children under rehabilitation for severe acute malnutrition in Bangladesh." PMC8183055. 2021.
• Saeed RR et al. "Impact of Isosorbide Diesters from Coconut and Sunflower Fatty Acids on Pediatric Atopic Dermatitis and the Skin Microbiome." PMC12842038. 2025.
• Karagounis TK et al. "Use of 'natural' oils for moisturization: Review of olive, coconut, and sunflower seed oil." Pediatric Dermatology. 2019.
• Grewling Ł et al. "Sunflower seed allergy." PMC5806758. 2018.
• Kim SH et al. "Anaphylaxis to Sunflower Seed with Tolerance to Sunflower Oil: A Case Report." PMC8305662. 2021.
• Sinha M et al. "Search for Allergens from the Pollen Proteome of Sunflower (Helianthus annuus L.)." PMC4587886. 2015.
• Cabanillas B et al. "Identification of Helianthus annuus allergens in subjects with allergy to sunflower." PMC4072161. 2014.
• EFSA. "Re-evaluation of lecithins (E 322) as a food additive." PMC7010002. 2017.
• Zhang H et al. "Chemical Composition and Antimicrobial and Antioxidant Activities of Essential Oil of Sunflower (Helianthus annuus L.) Receptacle." PMC7697854. 2020.
• Dermatology Times. "Skin barrier benefits of sunflower seed oil." 2026.
• Sarriá B et al. "Olive pomace oil can improve blood lipid profile: a randomized, blind, crossover, controlled clinical trial." PMC9941261. 2023.